CORRELATION BETWEEN NEPHROTOXICITY AND PHARMACOKINETIC PARAMETERS OF GENTAMICIN

被引:7
作者
ELSAYED, YM
机构
[1] Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451
关键词
D O I
10.1111/j.1365-2710.1994.tb00686.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gentamicin pharmacokinetics were determined in 26 critically ill adult patients. All had normal or only moderately reduced renal function based on serum creatinine concentration and clearance. The average half-life of elimination was 4.68 h, creatinine clearance was 3.9 1/h, and gentamicin clearance was 2.86 l/h. There was a highly significant correlation between the area under the serum concentration-time curves (AUC) and the peak and trough concentrations (r=0.908, 0.980, P<0.05, respectively). Serum gentamicin concentrations rose rapidly in 10 patients who showed deterioration of kidney function after 5 days of therapy. Gentamicin peak concentrations increased by 31%, while trough concentration increased by 121%. The mean percentage change in half-life was 68.49%, while the mean percentage change in renal function was 44.38%. Linear regression analysis of AUC versus the percentage change in kidney function revealed a significant increase in AUC with decrease in kidney function (r=0.909, P<0.05). There was a significant increase in half-life with decrease in kidney function (r=0.948, P<0.05).
引用
收藏
页码:267 / 271
页数:5
相关论文
共 23 条
[11]   PROSPECTIVE COMPARATIVE STUDY OF VARIABLE DOSAGE AND VARIABLE FREQUENCY REGIMENS FOR ADMINISTRATION OF GENTAMICIN [J].
GOODMAN, EL ;
VANGELDER, J ;
HOLMES, R ;
HULL, AR ;
SANFORD, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (04) :434-438
[12]  
GREVEL J, 1991, CLIN CHEM, V37, P1905
[13]   UNPREDICTABILITY OF SERUM CONCENTRATIONS OF GENTAMICIN - PHARMACOKINETICS OF GENTAMICIN IN PATIENTS WITH NORMAL AND ABNORMAL RENAL-FUNCTION [J].
KAYE, D ;
LEVISON, ME ;
LABOVITZ, ED .
JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (02) :150-154
[14]   CLINICAL NEPHROTOXICITY OF TOBRAMYCIN AND GENTAMICIN - A PROSPECTIVE-STUDY [J].
KUMIN, GD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (16) :1808-1810
[15]   THERAPEUTIC MONITORING OF AMINOGLYCOSIDE ANTIBIOTICS - AN APPROACH [J].
MANGIONE, A ;
SCHENTAG, JJ .
THERAPEUTIC DRUG MONITORING, 1980, 2 (02) :159-167
[16]   GENTAMICIN DOSAGES FOR RENAL INSUFFICIENCY - ADJUSTMENTS BASED ON ENDOGENOUS CREATININE CLEARANCE AND SERUM CREATININE CONCENTRATION [J].
MCHENRY, MC ;
GAVAN, TL ;
GIFFORD, RW ;
GEURKINK, NA ;
VANOMMEN, RA ;
TOWN, MA ;
WAGNER, JG .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (02) :192-+
[17]   RISK-FACTORS FOR NEPHROTOXICITY IN PATIENTS TREATED WITH AMINOGLYCOSIDES [J].
MOORE, RD ;
SMITH, CR ;
LIPSKY, JJ ;
MELLITS, ED ;
LIETMAN, PS .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (03) :352-357
[18]   EXPERIENCE IN MONITORING GENTAMICIN THERAPY DURING TREATMENT OF SERIOUS GRAM-NEGATIVE SEPSIS [J].
NOONE, P ;
PARSONS, TMC ;
PATTISON, JR ;
SLACK, RCB ;
GARFIELD.D ;
HUGHES, K .
BRITISH MEDICAL JOURNAL, 1974, 1 (5906) :477-481
[19]  
SCHENTAG JJ, 1977, JAMA-J AM MED ASSOC, V238, P327
[20]   GENTAMICIN TISSUE ACCUMULATION AND NEPHROTOXIC REACTIONS [J].
SCHENTAG, JJ ;
CUMBO, TJ ;
JUSKO, WJ ;
PLAUT, ME .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (19) :2067-2069